Tenax Therapeutics Net Worth
Tenax Therapeutics Net Worth Breakdown | TENX |
Tenax Therapeutics Net Worth Analysis
Tenax Therapeutics' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Tenax Therapeutics' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Tenax Therapeutics' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Tenax Therapeutics' net worth analysis. One common approach is to calculate Tenax Therapeutics' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Tenax Therapeutics' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Tenax Therapeutics' net worth. This approach calculates the present value of Tenax Therapeutics' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Tenax Therapeutics' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Tenax Therapeutics' net worth. This involves comparing Tenax Therapeutics' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Tenax Therapeutics' net worth relative to its peers.
To determine if Tenax Therapeutics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Tenax Therapeutics' net worth research are outlined below:
Tenax Therapeutics had very high historical volatility over the last 90 days | |
Tenax Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
Net Loss for the year was (7.71 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Tenax Therapeutics currently holds about 7.23 M in cash with (5.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. |
Tenax Therapeutics uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Tenax Therapeutics. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Tenax Therapeutics' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
12th of February 2024 Upcoming Quarterly Report | View | |
20th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
12th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Follow Tenax Therapeutics' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.78 M.Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tenax Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tenax Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tenax Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Tenax Therapeutics time-series forecasting models is one of many Tenax Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tenax Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Tenax Therapeutics Earnings per Share Projection vs Actual
Tenax Therapeutics Corporate Management
Doug Randall | Executive VP of Commercial and Bus. Operations | Profile | |
Eliot CPA | Interim Officer | Profile | |
Nancy Hecox | Gen Affairs | Profile | |
Esq CPA | Interim Officer | Profile |
Additional Tools for Tenax Stock Analysis
When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.